Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Johnson & Johnson Completes Acquisition of Mentor Corporation
Johnson & Johnson Completes Tender Offer for Mentor Corporation
Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered
The Shuman Law Firm Announces That a Class Action Lawsuit has Been Filed On Behalf of Investors of Mentor Corporation
Johnson & Johnson Announces Satisfaction of Regulatory Clearances Condition for its Proposed Acquisition of Mentor Corporation
Johnson & Johnson Extends Tender Offer for Mentor Corporation
Johnson & Johnson Begins Tender Offer to Acquire Mentor Corporation
Johnson & Johnson Announces Definitive Agreement to Acquire Mentor Corporation
Mentor to Present at the Piper Jaffray 20th Annual Health Care Conference
Mentor Reports Second Quarter Fiscal Year 2009 Financial Results and Completion of Enrollment in Post-Approval Study
Mentor Announces Webcast of Second Quarter Financial Results for Fiscal Year 2009
Mentor Corporation Announces Completion of PurTox(R) 3A Study
Mentor Corporation Announces Shareholders' Meeting Results and Adjournment; Declares Quarterly Cash Dividend
Mentor to Present at the Merrill Lynch Global Pharmaceutical Conference
Mentor Reports First Quarter Financial Results for Fiscal Year 2009
Mentor Announces Webcast of First Quarter Financial Results for Fiscal Year 2009
Mentor Corporation Declares Quarterly Dividend
Mentor Announces Completion of Enrollment in Phase I Trial for Botulinum Toxin Type A in Patients with Cervical Dystonia
Mentor Reports Fourth Quarter and Full Year Financial Results for Fiscal Year 2008 - May 27 2008 12:54AM
THE Aesthetic Show Advances $34 Billion Market - Jun 1 2008 6:49AM
Mentor Announces Webcast of Fourth Quarter and Full Year Financial Results for Fiscal Year 2008 and Guidance for Fiscal Year 2009 - Jun 2 2008 1:23AM
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
